natural killer cell

Open Access
Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody
YURINA SAITO, TSUYOSHI TAKAHASHI, KOSUKE HIRAMATSU, SATOSHI SERADA, MINORU FUJIMOTO, TOMOHARU OHKAWARA, TAKAHITO SUGASE, TAKAHIKO NISHIGAKI, KOJI TANAKA, YASUHIRO MIYAZAKI, TOMOKI MAKINO, YUKINORI KUROKAWA, KIYOKAZU NAKAJIMA, MAKOTO YAMASAKI, KEN J. ISHII, HIDETOSHI EGUCHI, YUICHIRO DOKI and TETSUJI NAKA

Anticancer Research June 2023, 43 (6) 2425-2432; DOI: https://doi.org/10.21873/anticanres.16410
You have access
Development of Antigen-specific Chimeric Antigen Receptor KHYG-1 Cells for Glioblastoma
CHUNG HYO KANG, YEONGRIN KIM, SO MYOUNG LEE, SANG UN CHOI and CHI HOON PARK

Anticancer Research April 2021, 41 (4) 1811-1819; DOI: https://doi.org/10.21873/anticanres.14947
You have access
Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 – Implications for Clinical Trials
HEIDI TÖRNROOS, HENRY HÄGERSTRAND and CHRISTER LINDQVIST

Anticancer Research January 2019, 39 (1) 107-112; DOI: https://doi.org/10.21873/anticanres.13085
You have access
Ex Vivo Expansion of Natural Killer Cells Using Cryopreserved Irradiated Feeder Cells
HEE-JO BAEK, JU-SUN KIM, MEESUN YOON, JE-JUNG LEE, MYUNG-GEUN SHIN, DONG-WOOK RYANG, HOON KOOK, SANG-KI KIM and DUCK CHO

Anticancer Research May 2013, 33 (5) 2011-2019;

Main menu